554
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Vilaprisan for treating uterine fibroids

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 497-505 | Received 05 Feb 2018, Accepted 26 Apr 2018, Published online: 07 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

F. Saritha, N. Aiswarya, R. Aswath Kumar & K.V. Dileep. (2023) Structural analysis and ensemble docking revealed the binding modes of selected progesterone receptor modulators. Journal of Biomolecular Structure and Dynamics 41:21, pages 12401-12410.
Read now
Giulio Evangelisti, Fabio Barra, Umberto Perrone, Nadine Di Donato, Stefano Bogliolo, Marcello Ceccaroni & Simone Ferrero. (2022) Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids. Expert Opinion on Drug Metabolism & Toxicology 18:7-8, pages 441-457.
Read now
Manuela Neri, Gian Benedetto Melis, Elena Giancane, Valerio Vallerino, Monica Pilloni, Bruno Piras, Alessandro Loddo, Anna Maria Paoletti & Valerio Mais. (2019) Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data. International Journal of Women's Health 11, pages 535-546.
Read now
Manuela Neri, Monica Pilloni, Anna Maria Paoletti, Gian Benedetto Melis, Bruno Piras, Silvia Ajossa, Maria Francesca Marotto, Valentina Corda, Alessandro Ronchi, Elena Giancane, Valerio Vallerino, Alessandra Saba, Pierina Zedda, Maria Paola Orani, Riccardo Cappai, Ferdinando Coghe & Valerio Mais. (2019) Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health. Gynecological Endocrinology 35:9, pages 756-761.
Read now
Mohamed Ali & Ayman Al-Hendy. (2018) Uterine fibroid therapy: the pharmacokinetic considerations. Expert Opinion on Drug Metabolism & Toxicology 14:9, pages 887-889.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.